FA Greco

488 total citations
12 papers, 377 citations indexed

About

FA Greco is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, FA Greco has authored 12 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in FA Greco's work include Lung Cancer Research Studies (7 papers), Neutropenia and Cancer Infections (5 papers) and Cancer therapeutics and mechanisms (3 papers). FA Greco is often cited by papers focused on Lung Cancer Research Studies (7 papers), Neutropenia and Cancer Infections (5 papers) and Cancer therapeutics and mechanisms (3 papers). FA Greco collaborates with scholars based in United States. FA Greco's co-authors include CD Buckner, John D. Hainsworth, CH Weaver, West Wh, Karen Hande, John D. Hainsworth, David H. Johnson, Thomas Alberico, Wei Li and Robert Birch and has published in prestigious journals such as Blood, Cancer Research and British Journal of Haematology.

In The Last Decade

FA Greco

12 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
FA Greco United States 10 221 128 90 86 73 12 377
Elisabeth Reiter Austria 13 74 0.3× 344 2.7× 117 1.3× 70 0.8× 26 0.4× 34 532
K Hattori Japan 13 85 0.4× 203 1.6× 122 1.4× 57 0.7× 31 0.4× 25 427
Alison Uzieblo United States 7 113 0.5× 75 0.6× 16 0.2× 89 1.0× 84 1.2× 8 353
L Vellekoop United States 10 141 0.6× 307 2.4× 80 0.9× 67 0.8× 9 0.1× 17 452
Laura Stephanie Miller United States 7 187 0.8× 225 1.8× 22 0.2× 27 0.3× 19 0.3× 11 408
Kathryn Fife United Kingdom 8 108 0.5× 57 0.4× 20 0.2× 54 0.6× 30 0.4× 12 283
Bik To Australia 10 169 0.8× 159 1.2× 27 0.3× 72 0.8× 10 0.1× 18 424
Carolyn Wasserheit United States 10 214 1.0× 49 0.4× 16 0.2× 47 0.5× 13 0.2× 15 319
CH Weaver United States 14 250 1.1× 248 1.9× 41 0.5× 39 0.5× 8 0.1× 16 411
P. Casassus France 8 129 0.6× 202 1.6× 106 1.2× 104 1.2× 18 0.2× 15 344

Countries citing papers authored by FA Greco

Since Specialization
Citations

This map shows the geographic impact of FA Greco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by FA Greco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites FA Greco more than expected).

Fields of papers citing papers by FA Greco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by FA Greco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by FA Greco. The network helps show where FA Greco may publish in the future.

Co-authorship network of co-authors of FA Greco

This figure shows the co-authorship network connecting the top 25 collaborators of FA Greco. A scholar is included among the top collaborators of FA Greco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with FA Greco. FA Greco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Peacock, N. W., et al.. (2009). A pilot study of adjuvant doxorubicin and cyclophosphamide followed by paclitaxel plus sorafenib in women with node positive or high-risk breast cancer.. Cancer Research. 69(2_Supplement). 2110–2110. 2 indexed citations
2.
Weaver, Charles H., Robert Birch, FA Greco, et al.. (1998). Mobilization and harvesting of peripheral blood stem cells: randomized evaluations of different doses of filgrastim. British Journal of Haematology. 100(2). 338–347. 70 indexed citations
3.
Hainsworth, John D., et al.. (1997). Phase I study of high dose etoposide phosphatase with filgrastim (G-CSF) in the treatment of advanced refractory malignancies. Investigational New Drugs. 15(4). 325–329. 2 indexed citations
4.
Weaver, CH, John D. Hainsworth, FA Greco, et al.. (1997). Treatment-related mortality in 1000 consecutive patients receiving high-dose chemotherapy and peripheral blood progenitor cell transplantation in community cancer centers. Bone Marrow Transplantation. 19(7). 671–678. 57 indexed citations
5.
Weaver, CH, Lee S. Schwartzberg, B Zhen, et al.. (1997). High-dose chemotherapy and peripheral blood stem cell infusion in patients with non-Hodgkin’s lymphoma: results of outpatient treatment in community cancer centers. Bone Marrow Transplantation. 20(9). 753–760. 25 indexed citations
6.
7.
Weaver, CH, FA Greco, B Zhen, et al.. (1997). A phase I–II study of high-dose melphalan, mitoxantrone and carboplatin with peripheral blood stem cell support in patients with advanced ovarian or breast carcinoma. Bone Marrow Transplantation. 20(10). 847–853. 21 indexed citations
8.
Hainsworth, John D. & FA Greco. (1994). Chronic Etoposide Schedules in the Treatment of Non-Hodgkin’s Lymphoma. Hämatologie und Bluttransfusion. 19(6 Suppl 14). 165–171. 9 indexed citations
9.
Wolff, Steven N., Rebecca Birch, Potukuchi Venkata Gurunadha Krishna Sarma, & FA Greco. (1987). Randomized dose-response evaluation of etoposide in small cell carcinoma of the lung: A southeastern cancer study group trial. Lung Cancer. 3(1). 48–48. 26 indexed citations
10.
Johnson, David H., et al.. (1986). Cisplatin and etoposide combination chemotherapy for refractory small cell carcinoma of the lung. Lung Cancer. 2(3). 227–227. 52 indexed citations
11.
Hainsworth, John D., Douglas H. Johnson, Karen Hande, et al.. (1986). Combination chemotherapy with vindesine, etoposide, and cisplatin in non-small cell lung cancer: A pilot study of the southeastern cancer study group. Lung Cancer. 2(4). 275–276. 9 indexed citations
12.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisabeth Reiter Breakdown of academic impact, for papers by K Hattori Breakdown of academic impact, for papers by Alison Uzieblo Breakdown of academic impact, for papers by L Vellekoop Breakdown of academic impact, for papers by Laura Stephanie Miller Breakdown of academic impact, for papers by Kathryn Fife Breakdown of academic impact, for papers by Bik To Breakdown of academic impact, for papers by Carolyn Wasserheit Breakdown of academic impact, for papers by CH Weaver Breakdown of academic impact, for papers by P. Casassus
Rankless by CCL
2026